Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-02-19

Clinical Trial Update: Effects of Perioperative Pregabalin for Post-Craniotomy Pain [Phase 4]

View source ↗

Summary

A Phase 4 study assessing perioperative pregabalin for craniotomy-related pain was withdrawn; it listed chronic postoperative pain and headache as conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Unity Health Toronto | Conditions: Chronic Postoperative Pain, Headache | Phase 4 | Status: WITHDRAWN